Study shows breastfeeding reduced risk for ER/PR-negative breast cancer

October 18, 2012

October 18, 2012 -- Breast-feeding reduces the risk for estrogen receptor-negative and progesterone receptor-negative breast cancer, according to a study conducted at Columbia University's Mailman School of Public Health. Researchers examined the association between reproductive risk factors -- such as the number of children a woman delivers, breast-feeding and oral contraceptive use - and found an increased risk for estrogen receptor- and progesterone receptor- (ER/PR) negative breast cancer in women who do not breast-feed. The results also indicated that having three or more children without breast-feeding was associated with an increased risk for ER/PR-negative breast cancer. ER/PR-negative breast cancer often affects younger women and has a poor prognosis.

The paper was presented at the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research.

The researchers used data from three sites of the Breast Cancer Family Registry, which includes women with and without breast cancer from the U.S., Canada and Australia. The study included 4,011 women with breast cancer and 2,997 population-based controls.

"Women who had children but did not breast-feed had about 1.5 times the risk for ER/PR-negative breast cancer," said Meghan Work, MPH, doctoral student in the Department of Epidemiology and first author. "If women breast-fed their children, there was no increased risk for ER/PR-negative cancer. This is particularly important as breast-feeding is a modifiable factor that can be promoted and supported through health policy," Work said.

The investigators also found that oral contraceptive use was not associated with ER/PR-negative cancer risk, with the exception of those formulations available before 1975. "These earlier formulations contained higher doses of estrogen and progestin than more recent versions," Work said.

These results are in line with previous findings that have demonstrated a breast-feeding benefit in triple-negative breast cancer, which includes estrogen and progesterone receptor negative cancers. "The consistency of the association with breast-feeding and estrogen receptor negative tumors across a number of studies is particularly noteworthy as there have been few modifiable risk factors identified for this tumor subtype," said Mary Beth Terry, PhD, associate professor of Epidemiology and senior author of the paper.
-end-
Support for the study was provided by the National Cancer Institute and Breast Cancer Research Foundation. Co-principal investigators were Drs. Esther John, Irene Andrulis, and John Hopper.

Columbia University's Mailman School of Public Health

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.